GMCR Stock Chart Mon, Jan 27th, 2014

New Post Public Reply Private Reply Replies (0) Message Board
chartguy89
GMCR Stock Chart and Technical Analysis - Mon, Jan 27th, 2014 $GMCR

Period  Moving Average  Price Change  Percent Change  Average Volume
5 Day  79.67  -1.33  -1.68%  1,960,980
20 Day  78.56  +1.82  +2.40%  2,245,400
50 Day  73.20  +17.81  +29.77%  3,310,042
100 Day  72.62  -7.53  -8.84%  3,682,409
200 Day  72.86  +19.41  +33.34%  3,882,539
Year to Date  79.14  +2.09  +2.77%  2,361,847

Period  Raw Stochastic  Stochastic %K  Stochastic %D  Average True Range
9 Day 20.57% 37.07% 56.23% 2.12
14 Day 20.57% 51.69% 72.32% 2.14
20 Day 51.00% 67.76% 79.81% 2.21
50 Day 83.27% 89.00% 93.13% 2.51
100 Day 66.84% 70.38% 72.17% 2.59

Period  Relative Strength  Percent R  Historic Volatility  MACD Oscillator
9 Day 44.16% 79.43% 32.11% -0.59
14 Day 51.03% 79.43% 25.76% -0.80
20 Day 53.90% 49.00% 23.84% +0.50
50 Day 53.51% 16.73% 41.56% +5.85
100 Day 53.34% 33.16% 42.50% +6.44

GMCR Stock Chart and Technical Analysis - Mon, Jan 27th, 2014
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Madrigal Pharmaceuticals Rewards New Employees with Equity Awards

Updated Category News Views 100

Overview of Equity Inducement Awards Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a leading biopharmaceutical organization, has recently initiated equity inducement awards to welcome new talent to its dynamic team. This initiative demonstrates Madrigal's commitment to fostering a strong workforce geared towards tackling significant health challenges related to metabolic...

Continue Reading
Boston Metal Welcomes Roy Harvey to Enhance Board Leadership

Updated Category News Views 202

Boston Metal Appoints Industry Leader Roy Harvey Boston Metal, a prominent technology company that is transforming the landscape of global metals production, has made a significant move by appointing Roy Harvey to its Board of Directors. This decision is pivotal as Boston Metal gears up for the commercial rollout of its groundbreaking Molten Oxide Electrolysis (MOE)...

Continue Reading
RBL LLC Partners with Carnrite Ventures for Biotech Growth

Updated Category News Views 125

RBL LLC Partners with Carnrite Ventures for Biotech Growth RBL LLC, a leading biotech venture creation studio, is excited to announce a significant investment from Carnrite Ventures. This partnership aims to enhance the rapid development of their robust pipeline of innovative therapeutic companies. According to Paul Wotton, the managing partner at RBL, "Carnrite's...

Continue Reading
OncoC4 and AcroImmune Merger: A Milestone in Immunotherapy

Updated Category News Views 106

Introducing the OncoC4 and AcroImmune Merger OncoC4, Inc. has just announced a thrilling merger with AcroImmune, a strategic union that promises to significantly boost OncoC4's standing in the biopharmaceutical sector. This collaboration brings together two companies dedicated to pioneering advancements in cancer treatment, with a special focus on developing unique...

Continue Reading
Rezolve AI Celebrates Major Investment Transforming AI Landscape

Updated Category News Views 92

Rezolve AI Excited About $30 Billion AI Investment Rezolve AI (NASDAQ: RZLV), well-known for its cutting-edge AI-driven commerce solutions, is enthusiastic about the recent announcement from Microsoft and BlackRock. These influential tech companies plan to invest $30 billion into AI infrastructure, a decision that could profoundly alter the landscape of the artificial...

Continue Reading